Investing

The 52-Week Low Club for Tuesday

down market
Source: Thinkstock
November 25, 2014: Here are four stocks among the 62 equities making new 52-week lows today.

Constellium NV (NYSE: CSTM) dropped about 3.1% today to post a new 52-week low of $16.39. The stock’s high is $32.61. Volume was about 15% above the daily average of around 1.4 million shares. The specialty aluminum company had no specific news today.

Medgenics Inc. (NYSEMKT: MDGN) dropped more than 14% on Tuesday to post a new 52-week low of $4.10 after closing at $4.78 on Monday evening. The stock’s post-IPO high is $39.45. Share volume is about 16-times the 52,000 daily average shares traded. The biotech firm said this morning that it will have a secondary offering of 5.125 million shares at $4.10.

Scorpio Bulkers Inc. (NYSE: SALT) posted a new 52-week low on Tuesday of $3.34. Based on Monday night’s closing price of $3.58 that’s a drop of about 6.7%. The stock’s 52-week high is $10.73. Trading volume is about 2.5-times the daily average of around 1.5 million shares. The Monaco-based dry bulk shipping firm had no specific news today.

Solazyme Inc. (NASDAQ: SZYM) posted a drop of about 2% today to post a fourth-consecutive new 52-week — and all-time — low of $2.59 against a 52-week high of $15.00. Volume is about 10% below the daily average of around 1.8 million shares. The biofuels maker announced last Thursday that the chairman of the board’s audit committee will resign by the end of the year, and the after-effects are still hitting the stock price.

ALSO READ: The Safest Cities in America

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.